These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 22028616)

  • 1. Molecular requirements for transformation of fallopian tube epithelial cells into serous carcinoma.
    Jazaeri AA; Bryant JL; Park H; Li H; Dahiya N; Stoler MH; Ferriss JS; Dutta A
    Neoplasia; 2011 Oct; 13(10):899-911. PubMed ID: 22028616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
    Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
    Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
    [No Abstract]   [Full Text] [Related]  

  • 3. [Morphologic changes of fallopian tubal epithelium in ovarian serous tumors].
    Wen J; Shi JL; Shen DH; Chen YX; Song QJ
    Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):433-7. PubMed ID: 22932451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin E1 deregulation occurs early in secretory cell transformation to promote formation of fallopian tube-derived high-grade serous ovarian cancers.
    Karst AM; Jones PM; Vena N; Ligon AH; Liu JF; Hirsch MS; Etemadmoghadam D; Bowtell DD; Drapkin R
    Cancer Res; 2014 Feb; 74(4):1141-52. PubMed ID: 24366882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucinous adenocarcinoma developed from human fallopian tube epithelial cells through defined genetic modifications.
    Shan W; Mercado-Uribe I; Zhang J; Rosen D; Zhang S; Wei J; Liu J
    Cell Cycle; 2012 Jun; 11(11):2107-13. PubMed ID: 22592533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A genetically engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high-grade serous carcinoma development.
    Sherman-Baust CA; Kuhn E; Valle BL; Shih IeM; Kurman RJ; Wang TL; Amano T; Ko MS; Miyoshi I; Araki Y; Lehrmann E; Zhang Y; Becker KG; Morin PJ
    J Pathol; 2014 Jul; 233(3):228-37. PubMed ID: 24652535
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Saini U; Suarez AA; Naidu S; Wallbillich JJ; Bixel K; Wanner RA; Bice J; Kladney RD; Lester J; Karlan BY; Goodfellow PJ; Cohn DE; Selvendiran K
    Cancer Res; 2018 Apr; 78(7):1739-1750. PubMed ID: 29339537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomorphologic and molecular analyses of fallopian tube fimbrial brushings for diagnosis of serous tubal intraepithelial carcinoma.
    Chui MH; Vang R; Wang TL; Shih IM; VandenBussche CJ
    Cancer Cytopathol; 2019 Mar; 127(3):192-201. PubMed ID: 30861338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling high-grade serous ovarian carcinogenesis from the fallopian tube.
    Karst AM; Levanon K; Drapkin R
    Proc Natl Acad Sci U S A; 2011 May; 108(18):7547-52. PubMed ID: 21502498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and functional characteristics of ovarian surface epithelial cells transformed by KrasG12D and loss of Pten in a mouse model in vivo.
    Mullany LK; Fan HY; Liu Z; White LD; Marshall A; Gunaratne P; Anderson ML; Creighton CJ; Xin L; Deavers M; Wong KK; Richards JS
    Oncogene; 2011 Aug; 30(32):3522-36. PubMed ID: 21423204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube.
    Yang J; Zhou Y; Ng SK; Huang KC; Ni X; Choi PW; Hasselblatt K; Muto MG; Welch WR; Berkowitz RS; Ng SW
    BMC Cancer; 2017 Jun; 17(1):422. PubMed ID: 28623900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Morphological features of the fimbria of the fallopian tube in pelvic serous adenocarcinoma].
    Guo DH; Pang SJ; Shen Y; Li Y
    Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):287-90. PubMed ID: 21575501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 signature and serous tubal in-situ carcinoma in cases of primary tubal and peritoneal carcinomas and serous borderline tumors of the ovary.
    Leonhardt K; Einenkel J; Sohr S; Engeland K; Horn LC
    Int J Gynecol Pathol; 2011 Sep; 30(5):417-24. PubMed ID: 21804388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular models of development of ovarian high-grade serous carcinoma: A review of cell of origin and mechanisms of carcinogenesis.
    Mei J; Tian H; Huang HS; Hsu CF; Liou Y; Wu N; Zhang W; Chu TY
    Cell Prolif; 2021 May; 54(5):e13029. PubMed ID: 33768671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transferrin facilitates the formation of DNA double-strand breaks via transferrin receptor 1: the possible involvement of transferrin in carcinogenesis of high-grade serous ovarian cancer.
    Shigeta S; Toyoshima M; Kitatani K; Ishibashi M; Usui T; Yaegashi N
    Oncogene; 2016 Jul; 35(27):3577-86. PubMed ID: 26549031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor (IGF) and hepatocyte growth factor (HGF) in follicular fluid cooperatively promote the oncogenesis of high-grade serous carcinoma from fallopian tube epithelial cells: Dissection of the molecular effects.
    Chu TY; Khine AA; Wu NY; Chen PC; Chu SC; Lee MH; Huang HS
    Mol Carcinog; 2023 Sep; 62(9):1417-1427. PubMed ID: 37265438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Both fallopian tube and ovarian surface epithelium are cells-of-origin for high-grade serous ovarian carcinoma.
    Zhang S; Dolgalev I; Zhang T; Ran H; Levine DA; Neel BG
    Nat Commun; 2019 Nov; 10(1):5367. PubMed ID: 31772167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic transformation of human ovarian surface epithelial cells with defined cellular oncogenes.
    Sasaki R; Narisawa-Saito M; Yugawa T; Fujita M; Tashiro H; Katabuchi H; Kiyono T
    Carcinogenesis; 2009 Mar; 30(3):423-31. PubMed ID: 19126650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Origin of ovarian epithelial inclusions and its relationship with the development of low-grade serous carcinoma].
    Xiang L; Li J; Wang LJ; Zheng WX; Kong BH
    Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):729-35. PubMed ID: 22321344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of p53 induces invasion of serous borderline ovarian tumor cells by accentuating PI3K/Akt-mediated suppression of E-cadherin.
    Cheng JC; Auersperg N; Leung PC
    Oncogene; 2011 Mar; 30(9):1020-31. PubMed ID: 20972462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.